Tirzepatide Eligibility: Can Anyone Take Tirzepatide for Weight Management?

Introduction

Many individuals across the United States are actively seeking effective and sustainable solutions for weight management. The journey to a healthier lifestyle can be complex, often marked by challenges that extend beyond diet and exercise alone. In recent years, a new class of medications has emerged, offering significant promise in this arena. Among them, tirzepatide has garnered considerable attention for its dual-action mechanism and impressive clinical results in weight reduction and blood sugar control. However, a common and critical question arises for many contemplating this option: can anyone take tirzepatide?

This post is designed to thoroughly explore the eligibility criteria for tirzepatide, diving deep into its mechanism, proven effectiveness, and the essential considerations for its use. We will navigate through who stands to benefit most from this medication, as well as the important medical conditions and factors that might preclude its use. Our goal is to provide a clear, authoritative, and empathetic guide that empowers you with the knowledge to understand if tirzepatide could be a suitable part of your weight management strategy. We believe that sustainable weight loss should be achieved through science, empathy, and a transparent approach, and this commitment guides our exploration. Throughout this article, we will also highlight how TrimRx supports individuals on their unique weight loss journeys with personalized, medically supervised care.

By the end of this comprehensive guide, you will have a much clearer understanding of tirzepatide’s role in weight loss, the specific health profiles it addresses, and the robust support systems available to ensure a safe and effective path forward. We’ll begin by unraveling the science behind tirzepatide and then move into a detailed discussion of its clinical applications, potential benefits, and crucial safety considerations, including how to determine if it’s the right fit for your individual needs.

Unpacking Tirzepatide: Mechanism and Medical Applications

Tirzepatide represents a significant advancement in the pharmaceutical landscape for metabolic health. It is a unique medication that activates two key incretin hormone receptors: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). This dual agonism is what sets tirzepatide apart and contributes to its profound effects on weight and blood sugar regulation.

The Dual-Action Advantage: GIP and GLP-1 Agonism

Normally, when we consume food, our gut releases natural hormones like GIP and GLP-1. These hormones play a crucial role in maintaining metabolic balance. They signal the pancreas to increase insulin release when blood sugar levels are high, helping to lower glucose. Additionally, they suppress appetite, slow down gastric emptying, and enhance the feeling of fullness after meals.

Tirzepatide mimics the action of both GIP and GLP-1, but with a prolonged and amplified effect compared to the body’s natural hormones, which are rapidly broken down. By activating both GIP and GLP-1 receptors, tirzepatide offers a comprehensive approach to metabolic regulation. The GLP-1 component primarily contributes to appetite suppression and delayed gastric emptying, while the GIP component is believed to offer additional benefits, potentially enhancing insulin secretion and glucose disposal in a glucose-dependent manner. This synergistic action leads to improved blood sugar control and significant weight reduction.

FDA Approvals: Zepbound and Mounjaro

Tirzepatide is available under two primary brand names, each approved for specific indications by the FDA:

• Zepbound®: This branded form of tirzepatide is FDA-approved for chronic weight management in adults. It is specifically indicated for individuals with obesity (defined as a body mass index (BMI) of 30 kg/m² or greater) or those who are overweight (BMI of 27 kg/m² or greater) with at least one weight-related medical condition. Such conditions can include type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea. It is crucial to understand that Zepbound is intended to be used as an adjunct to a reduced-calorie diet and increased physical activity, not as a standalone solution.
• Mounjaro®: This branded form of tirzepatide is FDA-approved to improve blood sugar control in adults with type 2 diabetes mellitus. It is used as an adjunct to diet and exercise. Mounjaro can be prescribed as a monotherapy or in combination with other diabetes medications, such as sulfonylureas, SGLT2 inhibitors, or metformin. While weight loss is a common and often beneficial side effect for individuals with type 2 diabetes taking Mounjaro, its primary approval is for glycemic control.

It’s important to note that while both Mounjaro and Zepbound contain the same active ingredient, tirzepatide, their specific FDA approvals and recommended uses differ. We also offer access to Compounded Tirzepatide and Oral Tirzepatide through our personalized assessment, which are provided through FDA-registered and inspected pharmacies. These compounded options serve to expand access to this powerful medication where appropriate.

The Power of Tirzepatide for Weight Loss: Clinical Evidence

The effectiveness of tirzepatide for weight loss has been rigorously studied in large-scale clinical trials, demonstrating impressive results that have reshaped expectations for medical weight management.

Significant Weight Reduction: The SURMOUNT-1 Trial

One of the landmark studies, SURMOUNT-1, showcased the profound impact of tirzepatide on body weight. In this 72-week trial, participants treated with tirzepatide achieved an average weight loss of up to 52 pounds with the highest dose. Specifically:

• Patients on the 15 mg weekly dose lost an average of 23.6 kg (52.0 lb).
• Patients on the 10 mg weekly dose lost an average of 22.2 kg (48.9 lb).
• Patients on the 5 mg weekly dose lost an average of 16.1 kg (35.5 lb).

These results are significantly higher than the average weight loss seen in the placebo group (2.4 kg or 5.3 lb) over the same period. This evidence underscores tirzepatide’s potential as a highly effective tool for individuals struggling with obesity or overweight conditions with comorbidities.

Head-to-Head Comparison: Tirzepatide vs. Semaglutide (SURMOUNT-5)

Further clinical investigation, particularly the SURMOUNT-5 trial, has provided insights into how tirzepatide compares to other GLP-1 agonists like semaglutide (Wegovy®). This head-to-head study, published in the New England Journal of Medicine, directly compared the efficacy of tirzepatide (Zepbound) and semaglutide (Wegovy) for the treatment of obesity over 72 weeks. The findings were compelling:

• Average Weight Loss: Tirzepatide led to an average weight loss of 50.3 pounds (22.8 kg), while semaglutide resulted in 33.1 pounds (15.0 kg).
• Percentage of Body Weight Lost: Participants on tirzepatide lost an average of 20.2% of their body weight, compared to 13.7% with semaglutide. This represents a 47% greater relative weight loss with tirzepatide.
• Achievement of 15% Weight Loss: A remarkable 64.6% of tirzepatide participants achieved at least 15% body weight loss, versus 40.1% for semaglutide.
• Waist Circumference Reduction: Tirzepatide also showed a greater reduction in waist circumference, averaging 7.2 inches (18.4 cm), compared to 5.1 inches (13.0 cm) with semaglutide.

These results highlight tirzepatide’s superior efficacy in achieving substantial weight loss compared to semaglutide in clinical trial settings. While individual results vary, and factors like adherence to diet and exercise patterns significantly impact outcomes, these studies offer strong evidence of tirzepatide’s potential. It is important to consider that these studies involve closely monitored participants, and real-world results may vary. However, the consistent findings across trials provide a robust foundation for its use in medical weight management.

Eligibility Criteria: Can Anyone Take Tirzepatide?

The question “can anyone take tirzepatide” is best answered by understanding specific medical criteria and contraindications. While tirzepatide offers a powerful avenue for weight loss and blood sugar control, it is not universally suitable.

General Qualifications for Weight Loss

For individuals seeking tirzepatide for weight management (Zepbound), the FDA approval outlines specific criteria:

• Obesity: A body mass index (BMI) of 30 kg/m² or greater.
• Overweight with Comorbidities: A BMI of 27 kg/m² or greater, accompanied by at least one weight-related medical condition such as:
  • Type 2 diabetes
  • High blood pressure (hypertension)
  • High cholesterol (dyslipidemia)
  • Obstructive sleep apnea (OSA)
  • Cardiovascular disease

It is explicitly stated that tirzepatide is not approved for individuals who are only slightly overweight. Its use is reserved for those facing significant health risks associated with their weight.

Qualifications for Type 2 Diabetes Management

For individuals with type 2 diabetes (Mounjaro), the criteria are focused on blood sugar control:

• Adults diagnosed with type 2 diabetes mellitus.
• The medication is used as an adjunct to diet and exercise to improve glycemic control.

Even within these broad categories, a thorough medical evaluation is essential to determine individual suitability. This is where TrimRx’s personalized approach comes into play. We offer a free assessment quiz to help individuals determine their eligibility for prescription weight loss medications like Compounded Tirzepatide, Oral Tirzepatide, Mounjaro®, Zepbound®, and others such as Compounded Semaglutide, Oral Semaglutide, Ozempic®, and Wegovy®. This initial step is vital for personalized care.

Key Contraindications: When Tirzepatide is NOT Recommended

Understanding who should not take tirzepatide is as important as knowing who can. There are several significant contraindications and warnings:

Thyroid C-Cell Tumors and MEN 2 Syndrome

• Personal or Family History of Medullary Thyroid Carcinoma (MTC): Tirzepatide, like other GLP-1 receptor agonists, has been shown to cause thyroid C-cell tumors in rodents. While it is unknown if it causes MTC in humans, it is contraindicated in individuals with a personal or family history of MTC.
• Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2): This genetic condition causes tumors in endocrine glands, including the thyroid. Individuals with MEN 2 syndrome should not take tirzepatide.

If you experience symptoms such as a lump or swelling in your neck, difficulty swallowing, persistent hoarseness, or shortness of breath, it is crucial to seek immediate medical attention.

Pancreatitis History

• History of Pancreatitis: While it is not definitively known if tirzepatide can be used in people who have had pancreatitis, caution is advised. Individuals with a history of acute pancreatitis should discuss this thoroughly with their healthcare provider. Signs of acute pancreatitis include severe stomach pain radiating to the back, nausea, and vomiting.

Severe Gastrointestinal Disease

• Severe Stomach Problems (e.g., Gastroparesis): Tirzepatide slows gastric emptying. For individuals already suffering from severe gastrointestinal issues like gastroparesis (stomach paralysis), this effect could exacerbate their condition. A thorough evaluation of digestive health is necessary.

Type 1 Diabetes

• Type 1 Diabetes: Tirzepatide is not approved for and should not be used in people with type 1 diabetes. It is specifically designed to work with the body’s existing insulin production in type 2 diabetes.

Pregnancy and Breastfeeding

• Pregnancy: Using tirzepatide during pregnancy can harm an unborn baby. Weight loss is generally not recommended during pregnancy. Women of childbearing potential should use effective contraception while on tirzepatide and discontinue the medication at least two months before planning a pregnancy. If you become pregnant while taking tirzepatide, inform your doctor immediately.
• Breastfeeding: The use of tirzepatide during breastfeeding has not been well-studied. While it may be recommended in certain situations, it requires careful consideration and discussion with a healthcare provider.

Allergic Reactions

• Known Allergy to Tirzepatide: Any individual with a known hypersensitivity or allergic reaction to tirzepatide or any of its ingredients should not take the medication. Symptoms of an allergic reaction can include hives, difficulty breathing, swelling of the face, lips, tongue, or throat.

These contraindications highlight the critical importance of a comprehensive medical consultation. Our commitment at TrimRx is to safety and personalized care, ensuring that every individual’s unique health profile is meticulously reviewed by a qualified healthcare professional before any treatment plan is initiated. We partner with FDA-registered and inspected pharmacies to provide our medications, upholding the highest standards of safety and quality.

The Journey with Tirzepatide: What to Expect

For those who qualify, beginning a tirzepatide regimen is a structured process that involves careful monitoring and lifestyle adjustments.

Administration and Dosing

Tirzepatide is administered as a once-weekly subcutaneous injection. The medication typically comes in a pre-filled pen or a single-dose vial. Patients or caregivers receive training on proper injection techniques, including how to rotate injection sites (thigh, abdomen, or upper arm) each week.

Treatment usually starts with a low dose, which is gradually increased over several weeks, typically not more often than once every four weeks. This titration schedule helps the body adjust to the medication and minimizes potential side effects. It’s vital to follow the prescribed dosing schedule exactly as directed by your healthcare provider. If a dose is missed, there are specific guidelines for when to take it or when to skip it, which your care team will explain.

Lifestyle Integration: Diet and Exercise

Tirzepatide is most effective when combined with a reduced-calorie diet and increased physical activity. It is not a magic bullet but a powerful tool that supports your efforts. We emphasize that sustainable weight loss comes from a holistic approach, integrating medical support with fundamental lifestyle changes. Our programs are designed to provide the comprehensive service you need, including doctor consultations and unlimited support, to help you navigate these changes effectively.

Medical Supervision and Monitoring

Ongoing medical supervision is non-negotiable when taking tirzepatide. Regular check-ups allow your healthcare provider to monitor your progress, assess for any side effects, and make necessary adjustments to your treatment plan. Blood tests may be ordered to evaluate your body’s response, particularly if you have type 2 diabetes, to monitor HbA1c levels. Our comprehensive service ensures this continuous support, providing you with everything you need, from medication and lab work to shipping, all with no hidden fees.

Understanding Potential Side Effects

Like all medications, tirzepatide can cause side effects. Awareness of these is crucial for patient safety and comfort. Most side effects are gastrointestinal and tend to be mild to moderate, often improving over time as the body adjusts to the medication.

Common Side Effects

The most frequently reported side effects of tirzepatide include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Dyspepsia (indigestion)
• Burping
• Fatigue
• Injection site reactions (e.g., redness, itching, swelling)

These common side effects usually do not require medical attention but should be reported to your healthcare provider if they persist or become bothersome. Strategies like starting with a low dose and gradually increasing it, as well as dietary modifications, can often help manage these symptoms.

Serious Side Effects

While less common, tirzepatide can be associated with serious side effects that require immediate medical attention:

• Pancreatitis: Inflammation of the pancreas can occur. Symptoms include severe stomach pain that may spread to your back, often accompanied by nausea and vomiting.
• Gallbladder Problems: Gallstones or inflammation of the gallbladder (cholecystitis) can occur. Symptoms may include severe stomach pain after eating, nausea, vomiting, fever, and yellowing of the skin or eyes.
• Acute Kidney Injury: Dehydration, often resulting from severe gastrointestinal side effects like vomiting and diarrhea, can lead to kidney problems. Symptoms include decreased urine output, swelling in the feet or ankles, and feeling tired or short of breath. Staying well-hydrated is critical.
• Severe Allergic Reactions: Hives, difficulty breathing, or swelling of the face, lips, tongue, or throat can be life-threatening and require emergency medical help.
• Hypoglycemia (Low Blood Sugar): While tirzepatide itself generally does not cause hypoglycemia in individuals without diabetes, it can occur when used in combination with other diabetes medications, such as insulin or sulfonylureas. Symptoms include headache, hunger, weakness, sweating, confusion, and a fast heartbeat.
• Diabetic Retinopathy Complications: In patients with type 2 diabetes, there have been reports of worsening diabetic retinopathy. Regular eye exams are important for diabetic patients.
• Suicidal Thoughts or Behavior: Although rare, some GLP-1 agonists have been associated with reports of suicidal thoughts or behavior. It is vital to report any changes in mood, behavior, or feelings to your doctor immediately.
• Thyroid C-Cell Tumors: As mentioned, rodent studies have shown a risk of thyroid C-cell tumors. While the risk in humans is unknown, any new lump, swelling, trouble swallowing, or hoarseness should be reported.

This list is not exhaustive, and other side effects can occur. It is crucial to maintain open communication with your healthcare provider about any concerns or symptoms you experience while taking tirzepatide. Our compassionate care and unlimited support at TrimRx are designed to respect every individual’s unique journey and address these concerns transparently.

Important Warnings and Interactions

Beyond eligibility and side effects, understanding potential warnings and medication interactions is critical for safe tirzepatide use.

Special Warnings

• Thyroid C-Cell Tumors/MEN 2: Re-emphasizing this, individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Syndrome type 2 (MEN 2) should not use tirzepatide. These are absolute contraindications.
• Acute Pancreatitis: If you develop symptoms of pancreatitis (severe abdominal pain, nausea, vomiting), discontinue tirzepatide and seek immediate medical attention.
• Gallbladder Disease: Be vigilant for symptoms of gallbladder problems (e.g., severe upper abdominal pain, nausea, vomiting, fever, chalky-colored stools).
• Acute Kidney Injury: Ensure adequate hydration, especially if experiencing gastrointestinal side effects, to prevent dehydration-related kidney issues.
• Hypersensitivity Reactions: Be aware of the signs of severe allergic reactions and seek emergency care if they occur.
• Diabetic Retinopathy: If you have diabetic retinopathy, closely monitor your vision and report any changes to your doctor.
• Severe Gastrointestinal Disease: Use with caution or avoid in individuals with severe gastrointestinal disease due to the medication’s effect on gastric emptying.

Medication Interactions

Tirzepatide can interact with other medications, primarily due to its effect on gastric emptying. This can alter the absorption rate of orally administered drugs.

• Oral Contraceptives: Tirzepatide can decrease the absorption of oral birth control pills, potentially reducing their effectiveness. Women taking oral contraceptives should consider using an alternative or additional barrier method of contraception for at least four weeks after starting tirzepatide and after each dose increase. Discuss contraceptive options thoroughly with your healthcare provider.
• Other Diabetes Medications: When tirzepatide is used with insulin or sulfonylureas, the risk of hypoglycemia increases. Your doctor may need to adjust the doses of these concomitant medications.
• Oral Medications in General: Because tirzepatide slows stomach emptying, it can affect how quickly other oral medications are absorbed. This may necessitate monitoring or adjustments for certain drugs. Always provide your healthcare team with a complete list of all medications, supplements, and herbal products you are currently taking.
• Alcohol: Alcohol consumption, especially in combination with other diabetes medications, can increase the risk of low blood sugar. Discuss alcohol use with your healthcare team.
• Upcoming Surgery: Inform your healthcare team if you are planning surgery or any procedure requiring anesthesia or deep sedation, as medication adjustments may be necessary.

This detailed review underscores the necessity of a comprehensive health assessment before starting tirzepatide. Our dedicated healthcare professionals prioritize your safety and will ensure all potential risks and interactions are thoroughly evaluated as part of your personalized treatment plan.

The TrimRx Approach to Personalized Weight Loss

At TrimRx, our journey began with a shared vision: to empower individuals to embrace healthier lifestyles. We merge cutting-edge telehealth innovations with clinically proven, effective weight loss solutions, always prioritizing safety and individualized care. We understand that effective weight management is rarely a one-size-fits-all solution, and our platform is built on the principles of science, empathy, and transparency.

Our Brand Story & Values

We believe in creating a user-friendly and supportive space where individuals receive personalized, medically supervised care, all designed to make sustainable weight loss attainable and tailored to the individual. Our brand is empathetic, innovative, trustworthy, supportive, results-oriented, and personalized. We offer compassionate care that respects every individual’s unique journey by combining advanced medical science with modern technology. This means:

• Science-Backed Solutions: We offer access to medications like Compounded Tirzepatide, Oral Tirzepatide, Mounjaro®, and Zepbound®, along with Compounded Semaglutide, Oral Semaglutide, Ozempic®, and Wegovy®, all provided through FDA-registered and inspected pharmacies. It’s important to clarify that compounded medications are not FDA approved, but the facilities that produce them are FDA-registered and inspected, ensuring quality and safety. For branded medications like Ozempic® and Zepbound®, we reference their FDA approval.
• Personalized Care: Your journey is unique, and your treatment plan should be too. We start with a comprehensive assessment to understand your health profile and goals.
• Medically Supervised: All prescription medications are overseen by licensed healthcare professionals who ensure your safety and tailor your treatment. It’s crucial to note that while we partner with FDA-registered and inspected pharmacies for medication shipping, TrimRx itself does not provide actual medical supervision. Our platform facilitates connections to independent licensed healthcare providers.
• Transparency: Our commitment to transparent service means our approach remains consistent, regardless of dosage changes. There are no hidden fees—our comprehensive service includes doctor consultations, medication, lab work, unlimited support, and shipping.
• Safety: We prioritize your well-being by exclusively partnering with FDA-registered and inspected pharmacies for the shipping of weight loss medications.

Our Personalized Weight Loss Programs

To determine if you qualify for our prescription weight loss medications, we invite you to take our free assessment quiz. This crucial first step helps our healthcare providers understand your medical history, current health status, and weight loss goals to create a personalized treatment plan that is safe and effective for you.

Our personalized programs may include:

• Compounded Semaglutide
• Oral Semaglutide
• Ozempic®
• Compounded Tirzepatide
• Oral Tirzepatide
• Mounjaro®
• Zepbound®
• Wegovy®

Each of these options is selected based on individual eligibility and needs, ensuring a tailored approach to achieving sustainable weight loss.

Quick-Access Support for Your Journey

We also understand that immediate support can be incredibly valuable for overall wellness during your weight loss journey, whether or not you qualify for prescription medication. For those looking for supplementary support without requiring a quiz or prescription, we offer quick-access supplements:

• GLP-1 Daily Support: Designed to support natural metabolic processes and complement your healthy lifestyle.
• Weight Loss Boost: Formulated to enhance your weight loss efforts by supporting energy and metabolism.

These supplements are available for immediate purchase, providing accessible tools to support your health and weight management goals.

We are dedicated to offering solutions that are not only effective but also compassionate and accessible. Our focus is on supporting you every step of the way, helping you achieve lasting results and a healthier, more vibrant life.

Conclusion

Understanding the intricacies of medications like tirzepatide is a pivotal step on any weight management journey. The answer to “can anyone take tirzepatide” is clearly nuanced: while it offers remarkable benefits for weight loss and blood sugar control, it is not a universal solution. Eligibility is strictly determined by medical criteria, including BMI, the presence of weight-related health conditions, and the absence of significant contraindications such as a history of certain thyroid cancers or pancreatitis. These guidelines are in place to ensure patient safety and optimize treatment outcomes.

The clinical data, particularly from trials like SURMOUNT-1 and SURMOUNT-5, underscore tirzepatide’s potent effects, offering hope for many who have struggled with conventional weight loss methods. However, its use demands a comprehensive understanding of potential side effects and drug interactions, coupled with diligent medical supervision and a commitment to lifestyle adjustments.

At TrimRx, we stand by our commitment to merging advanced medical science with compassionate, personalized care. We believe that informed decisions are the foundation of sustainable health. Our dedication to safety, transparency, and effective solutions is at the core of everything we do, providing a supportive environment for your weight loss journey. By partnering with FDA-registered and inspected pharmacies and offering comprehensive support—from doctor consultations and lab work to medication and unlimited guidance—we strive to make your path to better health both attainable and clear.

If you’re wondering if tirzepatide or other prescription weight loss medications might be right for you, we encourage you to take the first step towards a personalized path to wellness. Discover your eligibility and explore a tailored treatment plan by completing our free assessment quiz today. For immediate support that complements your health journey, explore our beneficial quick-access supplements like GLP-1 Daily Support and Weight Loss Boost. Your journey to a healthier, more fulfilling life is within reach, and we are here to support you every step of the way.

FAQ

Q1: What are the primary qualifications to be considered for tirzepatide for weight loss?

A1: To be considered for tirzepatide (Zepbound) for weight loss, individuals generally need to have a Body Mass Index (BMI) of 30 kg/m² or greater (obesity), or a BMI of 27 kg/m² or greater (overweight) with at least one weight-related medical condition such as type 2 diabetes, high blood pressure, or high cholesterol. It is crucial to combine the medication with a reduced-calorie diet and increased physical activity. To find out if you qualify, we recommend taking our free assessment quiz.

Q2: Are there any serious health conditions that would prevent someone from taking tirzepatide?

A2: Yes, several serious health conditions are absolute contraindications for tirzepatide. These include a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and a history of severe allergic reactions to tirzepatide. Individuals with a history of pancreatitis, severe gastrointestinal issues like gastroparesis, or type 1 diabetes should also avoid tirzepatide. A thorough medical review by a healthcare provider is essential to assess these risks.

Q3: How does TrimRx ensure the safety and effectiveness of tirzepatide for its patients?

A3: At TrimRx, we prioritize patient safety and efficacy through a medically supervised, personalized approach. Users complete a free assessment quiz reviewed by licensed healthcare providers to determine eligibility and create a tailored treatment plan. We partner exclusively with FDA-registered and inspected pharmacies for medication fulfillment, ensuring quality and adherence to regulatory standards. Our comprehensive service includes doctor consultations, necessary lab work, unlimited support, and transparent communication with no hidden fees, guiding you safely through your weight loss journey.

Q4: Besides prescription medications, what other support does TrimRx offer for weight management?

A4: Beyond our personalized prescription programs, TrimRx offers quick-access supplements designed to support overall wellness during your weight loss journey, available without a quiz or prescription. These include GLP-1 Daily Support, formulated to support natural metabolic processes, and Weight Loss Boost, designed to enhance energy and metabolism. These supplements provide additional tools to complement your healthy lifestyle choices.